Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes

Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes

BackgroundThis study was conducted to evaluate possible associations between Dietary Total Antioxidant Capacity (DTAC) and odds of non-alcoholic fatty liver disease (NAFLD) in people with type-2 diabetes mellitus (T2DM).Materials and methodsWe recruited two hundred people with T2DM, and evaluated th...

Full description

Bibliographic Details
Main Authors:	Marieh Salavatizadeh, Samira Soltanieh, Hossein Poustchi, Zahra Yari, Maryam Shabanpur, Asieh Mansour, Mohammad E. Khamseh, Fariba Alaei-Shahmiri, Azita Hekmatdoost
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Nutrition
Subjects:	NAFLD diabetes diet DTAC antioxidant
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2022.1037851/full

Similar Items

Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
by: Marieh Salavatizadeh, et al.
Published: (2023-08-01)

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
by: Samira Soltanieh, et al.
Published: (2023-03-01)

The association of dietary approach to stop hypertension (DASH) diet with hospitalization risk in patients with COVID-19
by: Ali Zamanian, et al.
Published: (2023-04-01)

Consumption of dairy products and odds of ulcerative colitis: An Iranian case–control study
by: Mohammad Reza Amini, et al.
Published: (2024-02-01)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
by: Saeede Saadati, et al.
Published: (2019-07-01)

Plant-based diet and COVID-19 severity: results from a cross-sectional study
by: Mohammad Ali Mansournia, et al.

Effects of Purslane Supplementation on Blood Lipid Profile: A Systematic Review and Meta-analysis of Randomized Controlled Trials
by: Behrouz Talaei, et al.
Published: (2022-06-01)

The association between dietary total antioxidant capacity and odds and severity of irritable bowel syndrome among Iranian adults: a cross-sectional study
by: Solaleh Saneie, et al.
Published: (2022-11-01)

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
by: Zahra Darabi, et al.
Published: (2019-02-01)

Behaviors and Mechanism of Quartz Flotation with DDA and DTAC
by: Tingxia Wang, et al.
Published: (2023-12-01)

The relationship of dietary total antioxidant capacity with sarcopenia and cardiometabolic biomarkers in type 2 diabetes patients
by: Nadya Baharirad, et al.
Published: (2022-02-01)

Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
by: Xiaoyu Wang, et al.
Published: (2021-12-01)

Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
by: Kaveh Naseri, et al.
Published: (2022-08-01)

Dietary phytochemical index and the risk of non-alcoholic fatty liver disease: A case-control study among Iranian adults
by: Ammar Salehi-sahlabadi, et al.
Published: (2022-12-01)

Nutrient patterns and non-alcoholic fatty liver disease in Iranian Adul: A case-control study
by: Ammar Salehi-sahlabadi, et al.
Published: (2022-09-01)

Comparison of Non-alcoholic Fatty Liver Disease Indexes and Hepatic Ultrasonography as Predictors of Hepatosteatosis in Patients with Obesity
by: Feray Akbaş, et al.
Published: (2024-03-01)

The role of leptin in non-alcoholic fatty liver disease
by: Elbadawy Reda, et al.
Published: (2006-01-01)

Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats
by: Ali Amirinejad, et al.
Published: (2021-09-01)

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
by: Zahra Yari, et al.
Published: (2023-09-01)

Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult
by: Jayanta Paul
Published: (2020-07-01)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Min-Sun Kwak, et al.
Published: (2012-12-01)

Adherence to oxidative balance scores and lower odds of non-alcoholic fatty liver disease: a case–control study
by: Mohammad Hassan Sohouli, et al.
Published: (2023-04-01)

Author Correction: Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
by: Zahra Yari, et al.
Published: (2024-01-01)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
by: Shun Ishido, et al.
Published: (2023-06-01)

Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review
by: Elena S. George, et al.
Published: (2022-01-01)

Association of dietary total antioxidant capacity, alternative healthy eating index, and dietary inflammatory index with semen quality in men seeking infertility treatment
by: Mahtab Dabagh, et al.
Published: (2023-10-01)

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?
by: Angeliki Papachristodoulou, et al.
Published: (2021-06-01)

Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran.
by: Bahareh Amirkalali, et al.
Published: (2014-09-01)

Interaction between sarcopenia and nonalcoholic fatty liver disease
by: Sae Kyung Joo, et al.
Published: (2023-02-01)

Genetic predisposition to nonalcoholic fatty liver disease: insights from ANGPTL8 gene variants in Iranian adults
by: Samira Saghafi, et al.
Published: (2023-09-01)

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial
by: Asieh Mansour, et al.
Published: (2021-04-01)

Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
by: Xunzhe Yin, et al.
Published: (2023-02-01)

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review
by: Panayiotis Kouis, et al.
Published: (2014-05-01)

Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: David Carneros, et al.
Published: (2020-11-01)

Prevalence of Non Alcoholic Fatty Liver Disease in patients with Parkinson Disease
by: Selahattin Vural, et al.
Published: (2019-04-01)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
by: Farzaneh Iravani, et al.
Published: (2018-10-01)

Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes
by: Zeinab Montazeri, et al.
Published: (2023-09-01)

Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the Liver
by: Dominika Maciejewska, et al.
Published: (2019-11-01)

CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
by: Xin Chu, et al.
Published: (2018-04-01)

Postprandial dysfunction in fatty liver disease
by: Josephine Grandt, et al.
Published: (2023-04-01)